Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults

NCT03893669 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of Influenza

Interventions

BIOLOGICAL: NBP607
BIOLOGICAL: Agrippal

Sponsor

SK Chemicals Co., Ltd.